The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.

The move comes a few weeks after the Texas A&M System issued a similar ban, which is being challenged in court.

Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.

The Florida Department of Education has stubbornly refused to produce written guidelines on sex ed, leaving school districts ...

Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilparencel’s path to market in the U.S., the release ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, ...

American Society of Regional Anesthesia and Pain Medicine guidelines highlight SSI prevention in regional anesthesia and ...

The list of grants related to vaccine hesitancy that officials ... were “antithetical to the scientific inquiry,” “often ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Here's a list of Columbia mayoral, city council, and school board candidates, as well as propositions voters will see on the ...

A college student from Anthony is speaking out after Blue Cross and Blue Shield of Kansas denied a medicine she has been ...